EXAC - Exactech, Inc.
| Previous Close | 49.67 |
| Open | 49.35 |
| Bid | 49.50 x 400 |
| Ask | 49.70 x 300 |
| Day's Range | 49.35 - 49.62 |
| 52 Week Range | 49.35 - 49.62 |
| Volume | 9,773 |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.•10 months ago
With A -96.98% Earnings Drop Lately, Did Exactech Inc (NASDAQ:EXAC) Underperform Its Industry?
Investors with a long-term horizong may find it valuable to assess Exactech Inc’s (NASDAQ:EXAC) earnings trend over time and against its industry benchmark as opposed to simply looking at aRead More...
- Zacks•10 months ago
Exactech (EXAC) Gets Acquired by TPG Capital, Goes Private
TPG Capital acquires Exactech (EXAC) with a view to cash in on its resources and gain a foothold in the orthopedics market.
- Business Wire•10 months ago
Exactech Announces Completion of Merger with TPG Capital
Exactech, Inc. , a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, is pleased to announce the successful completion of the previously announced merger agreement with TPG Capital, pursuant to which TPG has acquired all of the issued and outstanding common stock of Exactech.
- Business Wire•10 months ago
Exactech Shareholders Approve Merger Agreement with TPG Capital
Exactech , a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that at a Special Meeting of Shareholders held earlier today, Exactech’s shareholders approved the previously announced merger agreement with TPG Capital and certain of its affiliates, and approved the other two proposals described in Exactech’s proxy ...
- Moody's•11 months ago
Osteon Merger Sub, Inc. -- Moody's assigns B2 Corporate Family Rating to acquirer of Exactech
Moody's Investors Service, ("Moody's") assigned a B2 Corporate Family Rating and a B2-PD Probability of Default Rating to Osteon Merger Sub, Inc. ("Osteon"). Moody's also assigned a ...
- ACCESSWIRE•last year
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning the Sale of Exactech, Inc. to TPC Capital is Fair to Shareholders - EXAC
NEW YORK, NY / ACCESSWIRE / December 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Exactech, Inc. ("Exactech" or the "Company") ...
- Business Wire•last year
EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking More Cash for Shareholders of Exactech, Inc.
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc.
